Clinical Trial Detail

NCT ID NCT02614456
Title Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fox Chase Cancer Center
Indications

Advanced Solid Tumor

Therapies

Nivolumab

Interferon gamma

Age Groups: adult

No variant requirements are available.